ANDREA OERTLING: Open Payments
NPI 1114590585 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 119 payments from 14 companies in 2025. Trend: 2023 $1,555 · 2024 $1,484 · 2025 $1,773
Food & beverage: $1,589Education: $184
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 49 | $542 |
| GENZYME CORPORATION | 17 | $282 |
| Regeneron Healthcare Solutions, Inc. | 11 | $183 |
| LEO Pharma Inc. | 8 | $156 |
| ABBVIE INC. | 19 | $152 |
| E.R. Squibb & Sons, L.L.C. | 1 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Lilly USA, LLC | 2 | $51 |
| Janssen Biotech, Inc. | 2 | $50 |
Products named: DUPIXENT, Bimzelx, ADBRY, Sotyktu, SKYRIZI, RINVOQ, COSENTYX, EBGLYSS.
Industry payments across LA — which companies pay providers there.
